DHX9 and cervical carcinoma: High-risk human papillomavirus (HPV) impairs the interaction between MDM2 and DHX9 and the degradation of DHX9 by inhibiting the expression of lnc-CCDST, thereby promoting the movement and angiogenesis of cervical cancer (15).